Di Cui

Zhejiang Key Laboratory Of Tumor Molecular Diagnosis And Individualized Medicine
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Multi-omics and experimental validation identify USP54 as a prognostic deubiquitinase promoting pancreatic ductal adenocarcinoma progression within the immune microenvironment.

Multi-omics and experimental validation identify USP54 as a prognostic deubiquitinase promoting pancreatic ductal adenocarcinoma progression within the immune microenvironment.

Journal: Frontiers in immunology
Published: January 20, 2026

WTAP-mediated m6A modification of UBE2K drives the malignant progression of gastric cancer.

WTAP-mediated m6A modification of UBE2K drives the malignant progression of gastric cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 11, 2025

UBE2V1 Promotes Hepatocellular Carcinoma Progression by Forming a Positive Feedback Loop with HIF-1α.

UBE2V1 Promotes Hepatocellular Carcinoma Progression by Forming a Positive Feedback Loop with HIF-1α.

Journal: Research (Washington, D.C.)
Published: September 29, 2025

YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1.

YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1.

Journal: Cellular & molecular biology letters
Published: August 21, 2024

Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data.

Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data.

Journal: Journal of Cancer
Published: December 20, 2023

Immunogenic chemotherapy: great potential for improving response rates.

Immunogenic chemotherapy: great potential for improving response rates.

Journal: Frontiers in oncology
Published: October 06, 2023

Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer.

Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer.

Journal: Cancers
Published: June 09, 2022

MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic merits.

MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic merits.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: October 28, 2019

Transcriptome profiling of tolerogenic dendritic cells conditioned with dual mTOR kinase inhibitor, AZD8055.

Transcriptome profiling of tolerogenic dendritic cells conditioned with dual mTOR kinase inhibitor, AZD8055.

Journal: International immunopharmacology
Published: June 13, 2019

HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.

HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.

Journal: Journal of molecular cell biology
Published: March 28, 2019

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.

Journal: Theranostics
Published: August 27, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026